Outlook Therapeutics, Inc. 8-K

What Happened
Outlook Therapeutics, Inc. (OTLK) announced its financial results for the first fiscal quarter ended December 31, 2025 by issuing a press release and filing a Current Report on Form 8‑K on February 17, 2026. The press release with the quarterly results is furnished as Exhibit 99.1 to the 8‑K.

Key Details

• Filing date: February 17, 2026 (Form 8‑K, Item 2.02 - Results of Operations and Financial Condition).
• Quarter covered: First fiscal quarter ended December 31, 2025.
• Press release attached as Exhibit 99.1 to the 8‑K.
• The filing also includes the cover page interactive data file (Inline XBRL) as Exhibit 104.

Why It Matters
This 8‑K signals that Outlook has publicly released its latest quarterly earnings and financial condition information. Retail investors should review the attached press release for the specific earnings metrics (revenue, net income/loss, cash position, and management commentary), since those figures can affect valuation and near-term stock movement. The Form 8‑K itself furnishes the release but does not add additional financial statements or management changes beyond the announced results.